Frost & Sullivan Recognizes Vomaris with 2016 New Product Innovation Award

Electroceutical Wound Healing with Advanced Microcurrent Technology™ seen as Major Advancement in Wound Care, Providing Non-pharmacologic Solution to Antimicrobial Efficacy

TEMPE, Arizona, March 16, 2016 /PRNewswire/ -- Vomaris Innovations, Inc., a company specializing in electroceutical solutions for the wound care market and beyond, announced today that the company's Advanced Microcurrent Technology™ (AMT) platform has earned Frost & Sullivan's 2016 Best Practices Award for New Product Innovation for pioneering a battery-in-a-bandage technology that utilizes electrical energy for wound healing.

For the New Product Innovation Award, Frost & Sullivan analysts followed a 10-step process to research, identify and recognize best practices. They independently evaluated all award candidates across several benchmarking criteria in two key categories — New Product Attributes and Customer Impact – in which AMT scored best-in-class and earned the description of a "revolutionary wound dressing".  

Advanced Microcurrent Technology™ is the only platform in the world that powers a new generation dressing solution for wound and incisional care. Aiming to mimic the body's own physiologic electrical signals to direct cell migration and re-epithelialization, this novel technology employs embedded microcell batteries which generate microcurrents in the presence of moisture. Combined with its demonstrated efficacy against a broad-spectrum of microbes including drug-resistant¹ and biofilm-forming pathogens² and its ability to enhance cellular migration³, AMT creates an optimal environment for wound healing.  This positions Vomaris strongly to lead in the $3+ billion Advanced Wound Care Market.

"Vomaris has been committed to meeting the evolving challenges in today's wound care market, including multi-drug resistance and surgical site infections. We are proud to deliver a scientifically and clinically validated, non-pharmacologic solution to reduce risk of infection while promoting wound healing," commented Michael Nagel, President and CEO of Vomaris Innovations, Inc. "Recognition by Frost & Sullivan for our advances in electroceutical solutions affirms our efforts."

"By mimicking the body's physiological electrical signal generated during wound healing that directs cell migration and re-epithelialization, Vomaris electroceutical wound dressings provide an innovative healing solution, said Frost & Sullivan Research Analyst Debarati Sengupta. "Interestingly, no bacteria are known to be resistant to electricity, indicating that Advanced Microcurrent Technology™ as an innovative solution is here to stay."

Each year, Frost & Sullivan presents this award to the company that has developed an innovative element in a product by leveraging leading-edge technologies. The award recognizes the value-added features/benefits of the product and the potential it offers customers for increased ROI, which, in turn, improves customer acquisition and overall market penetration potential.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.

About Vomaris Innovations

Vomaris Innovations, Inc. is a privately held company specializing in electroceutical solutions for the wound care market and beyond. Vomaris' core technology platform, Procellera^® with Advanced Microcurrent Technology™ (AMT) is used in multiple acute and chronic wound care settings, including clinical, animal and consumer health. It is currently sold in the United States through strategic distribution partners and plans are underway for global expansion. Learn more at http://www.Procellera.com.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages almost 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

References

1. Kim H et al. Antibacterial Efficacy Testing of a Bioelectric Wound Dressing Against Clinical Wound Pathogens. The Open Microbiology Journal 2014; 8:15-21.
2. Banerjee J et al. (2015) Silver-Zinc Redox-Coupled Electroceutical Wound Dressing Disrupts Bacterial Biofilm. PLoS ONE 10(3): e0119531. doi:10.1371/journal.pone.0119531.
3. Banerjee J et al. (2014) Improvement of Human Keratinocyte Migration by a Redox Active Bioelectric Dressing. PLoS ONE 9(3): e89239. doi:10.1371/journal.pone.0089239